Βιβλιογραφία

2.1.1 Ξηρό, σκασμένο και «άγριο» δέρμα

  1. http://www.bepanthen.de/de/hautprobleme/schuppig-rissige-hautstellen/ 
  2. http://www.bepanthen.de/de/hautprobleme/schuppig-rissige-hautstellen/#tab_1

2.1.2 Πλένουμε τα χέρια μας - Φροντίζουμε το δέρμα μας

  1. https://www.who.int/infection-prevention/campaigns/clean-hands/advocacy-slides-2019_short.pdf?ua=1
  2. https://www.who.int/gpsc/5may/tools/who_guidelines-handhygiene_summary.pdf
  3. Lachapelle, J., Gimenez-Arnau, A., Metz, M., Peters, J. and Proksch, E., 2017. Best practices, new perspectives and the perfect emollient: optimizing the management of contact dermatitis. Journal of Dermatological Treatment, 29(3), pp.241-251
  4. Behroozy A, Keegel TG. Wet-work exposure: a main risk factor for occupational hand dermatitis.Saf Health Work 2014;5:175–180
  5. Loden M, Andersson AC. Effect of topically applied lipids on surfactant-irritated skin. Br J Dermatol1996; 134: 215–20.
  6. Ramsing DW, Agner T. Preventive and therapeutic effects of amoisturizer. An experimental study of human skin.
  7. Diepgen, T., Andersen, K., Chosidow, O., Coenraads, P., Elsner, P., English, J., Fartasch, M., Gimenez-Arnau, A., Nixon, R., Sasseville, D. and Agner, T., 2015. Guidelines for diagnosis, prevention and treatment of hand eczema. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 13(1), pp.e1-e22.

2.1.3. Μάθετε για τα ελαφρά εγκαύματα ή εγκαύματα πρώτου βαθμού

  1. http://www.mayoclinic.org/first-aid/first-aid-burns/basics/art-20056649
  2. Bayer Minor Wounds e-detailer 
  3. Bayer Minor Wounds e-detailer
  4. http://www.mayoclinic.org/first-aid/first-aid-burns/basics/art-20056649 
  5. http://www.nhs.uk/Conditions/Burns-and-scalds/Pages/Treatment.aspx 

2.1.4 Η δομή του δέρματός σου

  1. http://www.bepanthengamme.fr/fr/creme/#tab_0 Proksch, 
  2. Ehrhardt, Johanna M. Brandner, and Jens‐Michael Jensen. "The skin: an indispensable barrier." Experimental dermatology 17.12 (2008): 1063-1072. 
  3. http://www.bepanthengamme.fr/fr/creme/#tab_0 
  4. https://www.nursingtimes.net/clinical-archive/dermatology/understanding-the-structure-and-function-of-the-skin/205222.fullarticle

2.1.5 Ήλιος, δέρμα και φωτοευαισθησία

  1. Wacker M, Holick MF. Sunlight and Vitamin D: A global perspective for health. Dermato-endocrinology. Jan 1 2013;5(1):51-108. 
  2. Diffey BL. Solar ultraviolet radiation effects on biological systems. Physics in medicine and biology. Mar 1991;36(3):299-328. 
  3. Ravanat JL, Douki T, Cadet J. Direct and indirect effects of UV radiation on DNA and its components. Journal of photochemistry and photobiology. B, Biology. Oct 2001;63(1-3):88-102. 
  4. Norval M, Halliday GM. The consequences of UV-induced immunosuppression for human health. Photochemistry and photobiology. Sep-Oct 2011;87(5):965-977. 
  5. Vermeer BJ, Hurks M. The clinical relevance of immunosuppression by UV irradiation. Journal of photochemistry and photobiology. B, Biology. Aug 1994;24(3):149-154. 
  6. European Medicines Agency. ICH Guidance S10 on Photosafety Evaluation of Pharmaceuticals. Paper presented at: Committee for Human Medicinal Products 2015. 
  7. Khandpur S, Porter RM, Boulton SJ, Anstey A. Drug-induced photosensitivity: new insights into pathomechanisms and clinical variation through basic and applied science. The British journal of dermatology. Apr 2017;176(4):902-909. 
  8. Lim HW, Arellano-Mendoza MI, Stengel F. Current challenges in photoprotection. Journal of the American Academy of Dermatology. Mar 2017;76(3s1):S91-s99. 

2.2.2 Μάθετε για τα συγκάματα στα μωρά 

  1. Hoath, S.B. and Maibach, H.I. (2003) Neonatal skin: Structure and function.
  2. http://www.bepantolbaby.com.br/pt/familiaebebe/cuidados-com-assaduras/
  3. http://www.nhs.uk/Conditions/pregnancy-and-baby/Pages/Nappy-rash.aspx
  4. http://www.bepantolbaby.com.br/pt/familiaebebe/cuidados-com-assaduras/
  5. http://www.bepanthengamme.fr/fr/pommade/erytheme-fessier/
  6. http://www.nhs.uk/Conditions/pregnancy-and-baby/Pages/Nappy-rash.aspx
  7. Peters, M. British Medical Association Complete Home Medical Guide (4th Ed.). (2016)
  8. http://www.nhs.uk/Conditions/pregnancy-and-baby/Pages/Nappy-rash.aspx
  9. http://www.bepanthen.ie/en/bepanthensupsup-ointment/nappy-rash/

2.2.3 Συγκάματα στα μωρά

  1. Paulman, P.M., Paulman, A., Harrison, J.D., Nasir, L.S., Bryan, S.K. and Collier, D.S. (2011) Signs and symptoms in family medicine: A literature-based approach.
  2. http://www.bepanthen.ie/en/bepanthensupsup-ointment/care-tips/
  3. http://www.nhs.uk/Conditions/pregnancy-and-baby/Pages/Nappy-rash.aspx#rashprevention
  4. Schachner LA and Hansen RC (2011) Pediatric Dermatology
  5. Putet, G. et al. Bepanthen ointment in the prevention of diaper rash onpremature andfullterm babies: open pilot study.Real Pediatr 2001;63: 33 – 38.
  6. Biro et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis 2003; 49: 80-84
  7. Bissett D.L. Common cosmeceuticals. Clin Dermatol 2009; 27:435 - 445
  8. Camargo FB.. et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 2001;62 (4):361-370.
  9. Ebner F. et al. Topical Use of Dexpanthenol in Skin Disorders.. Am J Clin Dermatol 3, 2002;427-433
  10. Gehring W., Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung. 2000; 50 (7):659-663.
  11. Presto S. et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr 2001;76: 86-90
  12. Proksch E., Nissen H-P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 13, 2002;173-178 

2.3.1 Μπορεί το άγχος να προκαλέσει ατοπική δερματίτιδα;

  1. Griesemer, Robert D. "Emotionally triggered disease in a dermatologic practice." Psychiatric Annals 8.8 (1978): 49-56.
  2. Altemus, Margaret, et al. "Stress-induced changes in skin barrier function in healthy women." Journal of Investigative Dermatology 117.2 (2001): 309-317.
  3. Garg, Amit, et al. "Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders." Archives of dermatology 137.1
  4. Bockelbrink, A., et al. "Atopic eczema in children: another harmful sequel of divorce." Allergy 61.12 (2006): 1397-1402.

2.3.2 Ατοπική Δερματίτιδα ή Έκζεμα

  1. http://www.bepanthen.de/de/hautprobleme/geroetete-juckende-hautstellen/#tab_2
  2. http://www.nhs.uk/Conditions/Eczema-%28atopic%29/Pages/Treatment.aspx
  3. http://www.mayoclinic.org/diseases-conditions/eczema/basics/treatment/con-20032073
  4. https://www.bepanthengamme.fr/fr/sensicalm/
  5. http://www.bepanthengamme.fr/fr/sensicalm/
  6. https://www.bepanthengamme.fr/fr/sensicalm/#tab_2 

2.3.3 Τήρηση ενός ημερολογίου για την υγεία του δέρματος

  1. Williams, Hywel C. Atopic dermatitis: the epidemiology, causes and prevention of atopic eczema. Cambridge University Press, 2000. Σελίδα 25
  2. Werfel, T., et al. "Eczematous reactions to food in atopic eczema:position paper of the EAACI and GA2LEN." Allergy 62.7 (2007): 723-728.
  3. http://www.who.int/dietphysicalactivity/fruit/en/index2.html
  4. Ehlers I, Worm M, Sterry W, Zuberbier T. Sugar is not an aggravating factor in atopic dermatitis. Acta Dermatol Venereol 2001, 81: 282-284.

2.3.4 Τι είναι η Ατοπική Δερματίτιδα

  1. http://www.bepanthen.de/de/hautprobleme/geroetete-juckende-hautstellen/#tab_1
  2. http://www.mayoclinic.org/diseases-conditions/eczema/basics/causes/con-20032073
  3. http://www.bepanthengamme.fr/fr/sensicalm/#tab_2
  4. http://www.mayoclinic.org/diseases-conditions/eczema/basics/symptoms/con-20032073
  5. http://www.bepanthengamme.fr/fr/sensicalm/ 

2.3.5 Πώς να αντιμετωπίσω το έκζεμα στο πρόσωπό μου;

  1. Hoeger, P. H., et al. "The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial." British Journal of Dermatology 160.2 (2009): 415-422
  2. http://www.mayoclinic.org/diseases-conditions/eczema/basics/treatment/con-20032073
  3. Ring, Johannes, et al. "Guidelines for treatment of atopic eczema (atopic dermatitis) part I." Journal of the European Academy of Dermatology and Venereology 26.8 (2012): 1045-1060.
  4. http://www.nhs.uk/conditions/emollients/Pages/Introduction.aspx
  5. http://www.eczemacanada.ca/en/For-Adults/Makeup-and-Cleansers
  6. Ring, Johannes, et al. "Guidelines for treatment of atopic eczema (atopic dermatitis) part I." Journal of the European Academy of Dermatology and Venereology 26.8 (2012): 1045-1060.
  7. https://nationaleczema.org/eczema/child-eczema/infants-toddlers/

2.3.6 Γιατί έχω φαγούρα στο πρόσωπό μου;

  1. Willis, C. M., et al. "Sensitive skin: an epidemiological study." British Journal of Dermatology 145.2 (2001): 258-263.
  2. Sicherer, Scott H., and Hugh A. Sampson. "9. Food allergy." Journal of Allergy and Clinical Immunology 117.2 (2006): S470-S475.
  3. http://www.mayoclinic.org/diseases-conditions/hay-fever/basics/treatment/con-20020827
  4. http://www.nhs.uk/conditions/Prickly-heat/Pages/Introduction.aspx
  5. Mehta, Surjit Singh, and Belum Siva Nagi Reddy. "Cosmetic dermatitis–current perspectives." International journal of dermatology 42.7 (2003): 533-542.
  6. http://www.mayoclinic.org/diseases-conditions/itchy-skin/basics/lifestyle-home-remedies/con-20028460 
  7. Hairong, DONG Yinmao WANG Changtao YU. "The Elementary Study of Cosmetic with Cucumber Juice [J]." Flavour Fragrance Cosmetics 3 (2007): 006.

2.5.1 Μάθετε για την Ξηροφθαλμία

  1. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009; 3:405-4122. 
  2. Yao. W. Dry Eye Syndrome: An Update in Office Management. The American Journal of Medicine. 2011; 124:1016-1018
  3. Golden M.I. Dry Eye Syndrome -StatPearls -NCBI Bookshelf. 2020:1-7

2.5.2 Ξηροφθαλμία

  1. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009; 3:405-412
  2. https://www.eyeeco.com/blog/2355-simple-lifestyle-changes-good-dry-eyes.htmlAccessed 02.12.2020
  3. Golden M.I. Dry Eye Syndrome -StatPearls -NCBI Bookshelf. 2020:1-7
  4. Yao. W. Dry Eye Syndrome: An Update in Office Management. The American Journal of Medicine. 2011; 124:1016-1018
  5. AAO PPP Cornea/External Disease Committee, Hoskins Center for Quality Eye Care. Dry Eye Syndrome PPP -2018
  6. https://nyulangone.org/conditions/dry-eye-syndrome/treatments/lifestyle-modifications-for-dry-eye-syndrome Accessed 02.12.2020

3.1.1.1 Bepanthol® Baby Balm

  1. Peltier, E.; Mekideche, K.; Branka, J.E.; Trapp, S. New Insights in the Skin Protective Activity of a Dexpanthenol Containing Formula (Bepanthen) in a Diaper Rash-Like Model. J. Cosmet. Dermatol. Sci. Appl. 2020, 10, 76–8
  2. Proksch, E., de Bony, R., Trapp, S., Boudon, S. Topical use of dexpanthenol: a 70th anniversary article. Journal of Dermatological Treatment. 2017 28(8), 766-773
  3. Putet, G. et al. Bepanthen ointment in the prevention of diaper rash on premature and full-term babies: open pilot study.Real Pediatr 2001;63: 33 – 38Peltier, E.; Mekideche, K.; Branka, J.E.; Trapp, S. New Insights in the Skin Protective Activity of a Dexpanthenol Containing Formula (Bepanthen) in a Diaper Rash-Like Model. J. Cosmet. Dermatol. Sci. Appl. 2020, 10, 76–84.
  4. Peltier, E.; El-Shazly, MA.; Blenkiron, P.; Crowther, JM. P1136 Two In-vitro studies comparing the friction lowering and protective properties of diaper care products; EADV: Vienna, Austria, 2020 [Abstract; e-poster]
  5. Αξιολόγηση από φροντιστές μωρών και μητέρες σχετικά με την ευκολία εφαρμογής και αφαίρεσης του προϊόντος. Test report, Bayer Consumer Health, March 2020.
  6. Dubecq J.P., Detchart M. Study on a dexpanthenol containing ointment in prevention and treatment of cracked nipples. Med Praticienne 1977; 665: 154-155.
  7. Atherton, D., Proksch, E., Schauber, J., & Stalder, J. F. (2015). Irritant diaper dermatitis supplement part 1: best practice management. -Selfcare 6(S1):1-11

3.2.1.1 Bepanthol® Sensiderm Eczema

  1. Οδηγίες χρήσης Bepanthol® Sensiderm Eczema, Bayer 2015. Διαβάστε το Φύλλο Οδηγιών Χρήσης
  2. Stettler H. Improved itch relief with new product formulation for topical treatment in patients with mild-to-moderate atopic dermatitis: results from an exploratory trial. Key Opinions in Medicine.2016;11(4):1-7.
  3. Darsow U, Wollenberg A, Simon D et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24:317–328.
  4. Cork M, Danby S. Skin barrier breakdown: a renaissance in emollient therapy. British Journal of Nursing. 2009;Vol 18, No 14
  5. Ellis C et al. Br J Dermatol. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. 2003;148(Suppl 63):3–10.
  6. Rawlings AV. Trends in stratum corneum research and the management of dry skin conditions. Int J Cosmet Sci. 2003; 25(1-2):63-95.
  7. Proksch E, Bradner MJ, Jensen JM. The skin: an indispensable barrier. Experimental Dermatology. 2008;17:1063-1072
  8. Abiko Y, Tomikaw M, Shimizu M. Enzymatic conversion of pantothenylalcohol to pantothenic acid. J Vitaminology.1969;15: 59-69.
  9. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Arzneimittelforschung. 2000 Jul;50(7):659-63.
  10. Ebner F, Heller A, Rippke F, Tausch I. Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol. 2002; 3(6): 427-433.
  11. Proksch E, Nissen HP. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. Journal of Dermatological Treatment. 2002;13:173-178.
  12. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. British Journal of Dermatology. 2008;159(1):23-34.
  13. Yosipovitch G, Papoiu ADP. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8:306–311.

3.3.1.1 Bepanthol® Σπρέι Αφρού

  1. Karajiannis H. et al. BEPANTHEN BURN RELIEF FOAM SPRAY: Scientific Rationale, Switzerland, 2001

3.3.2.1 Bepanthol® Κρέμα

  1. Biro K. et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis. 2003; 49: 80-84.
  2. Bissett DL. Common cosmeceuticals. Clin Dermatol. 2009;27: 435 – 445.
  3. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 2011;62 (4):361-370.
  4. Ebner F. et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol. 2002;3:427-433.
  5. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Drug Research. 2000;50 (ΙΙ): 659 – 663
  6. Presto S. et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr. 2001;76, 86-90.
  7. Proksch E, Nissen H.P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment. 2002;13, 173-178.
  8. Goujon C. et al. Study on the efficacy and tolerance of Bepanthen cream on irritant hand dermatitis. Réalités Thérapeutiques en Dermato-Vénérologie. 2001;2-11
  9. Leyden JL, Lavker R. Photodamage and Dry Skin. J Toxicol – Cut & Ocular Toxicol. 2002; 21(3): 255-263
  10. Proksch E, de Bony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. Journal of Dermatological Treatment. 2017; 28(8): 766-773 

3.3.2.2 Bepanthol® Balm

  1. Biro et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis 2003; 49: 80-84
  2. Bissett D.L. Common cosmeceuticals. Clin Dermatol 2009; 27:435 - 445
  3. Camargo FB. et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 2001;62 (4):361-370.
  4. Ebner F. et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 3, 2002;427-433
  5. Gehring W., Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung. 2000; 50 (7):659-663.
  6. Presto S. et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr 2001;76: 86-90
  7. Proksch E., Nissen H-P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 13, 2002;173-178
  8. Goujon-Henry C. et al. Randomized single-blind pilot comparison study of the efficacy and tolerability of Bepanthen Ointment in subjects with bilateral dryness of the hands. Réalités Thérapeutiques en Dermato-Vénérologie. 1997;107: 81-90
  9. Olsavszky R. et al. Skin barrier restoration upon topical use of two 5% dexpanthenol water-in-oil formulations on freshly tattooed skin: results from a single-blind prospective study. Wounds International 2019; Vol 10, Issue 1:33-39
  10. Dubecq J.P., Detchart M. Study on a dexpanthenol containing ointment in prevention and treatment of cracked nipples. Med Praticienne 1977; 665: 154-155.
  11. Putet, G. et al. Bepanthen ointment in the prevention of diaper rash on premature and fullterm babies: open pilot study. Real Pediatr 2001;63: 33 – 38.

3.3.2.3 Bepanthol® Tattoo Balm

  1. Κλινική μελέτη δέρμα με νέο tattoo, Bayer 2018. 
  2. Αποτελέσματα ερωτηματολογίου που συμπληρώθηκε από 56 άτομα με νέο tattoo σε επισκέψεις τους τη 2η, 7η και 14η  ημέρα μετά το τατουάζ. Η Bepanthol® Tattoo Balm εφαρμόστηκε στο νέο τατουάζ 4-8 φορές/ημέρα για 14 ημέρες. Κλινική μελέτη δέρμα με νέο tattoo, Bayer 2018.
  3. Biro K. et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis. 2003;49, 80 – 84 
  4. Bissett DL. Common cosmeceuticals. Clin Dermatol. 2009;27, 435 – 445
  5. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 2001;62 (4), 361 – 370 
  6. Ebner F et al. Topical use of dexpanthenol in skin sisorders. Am J Clin Dermatol. 2002; 3, 427 – 433 
  7. Gehring W & Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung. 2000;50 (7), 659 – 663 
  8. Goujon N. et al. Randomized single-blind pilot comparison study of the efficacy and tolerability of Bepanthen Ointment in subjects with bilateral dryness of the hands. Réalités Thérapeutiques en Dermato-Vénérologie. 1997;107, 81 – 90 
  9. Presto S. et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr. 2001;76, 86 – 90 
  10. Proksch E. & Nissen H-P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation. J Dermatol Treatment. 2002;13, 173 – 178 
  11. Proksch E., de Bony R., Trapp S., & Boudon S. Topical use of dexpanthenol: a 70th anniversary article. Journal of Dermatological Treatment. 2017;28(8), 766-773 
  12. Olsavszky R. et al. Skin barrier restoration upon topical use of two 5% Dexpanthenol water-in-oil formulations on freshly tattooed skin: results from a single-blind prospective study. Wounds International 2019(10);1:33-9
  13. In vitro test, Bayer 2010
  14. Σύνθεση προϊόντος

3.4.1.1 Bepanthol® Ενυδατική Κρέμα Προσώπου

  1. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Drug Research 2000;50 (ΙΙ): 659 – 663
  2. Camargo F.B. et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci. 62, 2011; (4):361-370.
  3. Biro et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis. 2003; 49, 80-84
  4. Bissett DL. Common cosmeceuticals. Clin Dermatol 2009; 27, 435 - 445
  5. Ebner et al. Topical Use of Dexpanthenol in Skin Disorders.. Am J Clin iDermatol 3, 2002;427-433
  6. Presto et al. Stimulation of epidermal regeneration by 5% dexpanthenol – results of a placebo-controlled double-blind study. Z f Hautkr 76,2001; 86-90
  7. Proksch & Nissen. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 13, 2002; 173-178
  8. Burke KE. Photodamage of the skin: protection and reversal with topical antioxidants. J Cosmet Dermatol 2004; 3: 149-155.
  9. Dreher F, Maibach HI (2001) Protective effects of topical antioxidants in humans. In: Thiele J, Elsner P (eds.) Oxidants and antioxidants in cutaneous biology. Curr Probl Dermatol, 29:157-164
  10. Nachbar F, Korting HC (1995), The role of vitamin E in normal and damaged skin, J Mol Med, 73: 7-17
  11. Lupo M, Antioxidants and Vitamins in Cosmetics. Clinics in Dermatology, 2001;19:467-473
  12. Sharma Bh. and Sharma Ar. Future prospect of nanotechnology in development of anti-ageing formulations. International Journal of Pharmacy and Pharmaceutical Sciences, 2012, Vol 4, Issue 3 57-66

3.4.1.2 Bepanthol® Intensive Κρέμα Προσώπου-Ματιών

  1. Κλινικές μελέτες προϊόντος
  2. Biro K et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis. 2003; 49, 80-84.
  3. Bissett DL. Common cosmeceuticals. Clin Dermatol 2009;27, 435 – 445.
  4. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci 2011;62 (4):361-370.
  5. Ebner F et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 2002;3:427-433.
  6. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. British Journal of Dermatology. 2008;159(1):23-34.
  7. Gehring W, Fluhr J, Gloor M. Influence of vitamin E acetate on stratum corneum hydration, Arzneimittelforschung 48, 1998; (7), 772-775
  8. Gehring W., Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung 2000;50 (7):659-663.
  9. Presto S et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr 2001;76, 86-90.
  10. Proksch E., Nissen H.P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 2002;13, 173-178.

3.4.2.1 Bepanthol® Αντιρυτιδική Κρέμα για Πρόσωπο-Μάτια-Λαιμό

  1. Κλινική αξιολόγηση 40 γυναικών μετά από 28 ημέρες
  2. Εσωτερική θρέψη επιδερμίδας λόγω μειωμένης διαδερμικής απώλειας νερού.
  3. Προσωπικές αξιολογήσεις, 40 γυναίκες, χρήση 4 εβδομάδες, 2 φορές/ημέρα.

3.5.1.1 Bepanthol® Γαλάκτωμα Σώματος

  1. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Drug Research 2000;50 (ΙΙ): 659 - 663
  2. Ebner F. et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 2002;3:427-433.
  3. Del Rosso J., Levin J.SKIN STRUCTURE AND FUNCTION, The Clinical Relevance of Maintaining the Functional Integrity of the Stratum Corneum in both Healthy and Disease-affected Skin, The Journal of Clinical and Aesthetic Dermatology, Sept. 2011; Vol.4, Num. 9
  4. Rawlings A.V. et al. Skin Moisturisation. Dry and Xerotic Skin Conditions. Marcel Dekker Inc., New York, 2002;6:119-120
  5. Κλινικές μελέτες προϊόντος

3.5.1.2 Bepanthol® Κρέμα Χεριών

  1. Biro K et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis. 2003; 49, 80-84
  2. Bissett DL. Common cosmeceuticals. Clin Dermatol 2009;27, 435 – 445
  3. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci 2011;62 (4):361-370
  4. Ebner F et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 2002;3:427-433
  5. Gehring W., Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung 2000;50 (7):659-663
  6. Presto S et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr 2001;76, 86-90
  7. Proksch E., Nissen H.P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 2002;13, 173-178
  8. Κλινικές δοκιμές προϊόντος

3.5.2.1 Bepanthol® Αφρόλουτρο

  1. Bouwstra J, Gooris G, Ponec M. Skin lipid organisation, Composition and Barrier function. IFSCC magazine 2007:10, 297 - 307
  2. Bissett DL. Common cosmeceuticals. Clin Dermatol 2009;27, 435 - 445
  3. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci 2011;62 (4):361-370
  4. Ebner F et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 2002;3:427-433
  5. Fluhr JW, Darlenski R, Surber C. Glycerol and the skin: holistic approach to its origin and functions. British Journal of Dermatology 2008;159(1):23-34
  6. Gehring W, Gloor M.Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Results of a human in vivo study. Arzneimittelforschung 2000;50 (7):659-663
  7. Orth DS, Appa Y. Glycerine: A Natural Ingredient for Moisturizing Skin. In: Loden M, Maibach HI, (ed). Dry Skin and Moisturizers. Boca Raton, Florida, CRC Press, 2000 (p. 213-28)

3.6.1 Bepanthene® Eye Drops

  1. Οδηγίες Χρήσης Bepanthene®  Eye Drops
  2. Σύνθεση Bepanthene®EyeDrops
  3. Causes of Dry Eye. National Eye Institute. Accessed 04.08.2020. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye/causes-dry-eye
  4. Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009; 3:405-412
  5. Milicic N. et al. Corneal epithelialization after photorefractive keratectomy using sodium hyaluronate/dexpanthenol preservative free eye drops, ESCRS Barcelona 2015

4.0 Σχετικά με τη Bepanthol® 

  1. Biro K. et al. Effect of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study Contact Dermatitis. 2003; 49, 80-84. 
  2. Bissett DL. Common cosmeceuticals. Clin Dermatol 2009;27, 435 – 445. 
  3. Camargo FB et al. Skin moisturizing effects of panthenol-based formulations. J Cosmet Sci 2011;62 (4):361-370. 
  4. Ebner F. et al. Topical Use of Dexpanthenol in Skin Disorders. Am J Clin Dermatol 2002;3:427-433. 
  5. Gehring W, Gloor M. Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration. Drug Research 2000;50 (ΙΙ): 659 – 663 
  6. Presto S. et al. Stimulation of epidermal regeneration by 5% dexpanthenol - results of a placebo-controlled double-blind study. Z f Hautkr 2001;76, 86-90. 
  7. Proksch E, Nissen H.P. Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate- induced irritation. J Dermatol Treatment 2002;13, 173-178. 
  8. Goujon Ν. et al. Randomized single-blind pilot comparison study of the efficacy and tolerability of Bepanthen Ointment in subjects with bilateral dryness of the hands. Réalités Thérapeutiques en Dermato-Vénérologie. 1997;107: 81-90 
  9. https://www.bepanthen.com.au/en/about-bepanthen/

5.1 Εκτεταμένη χρήση μάσκας; Βοηθήστε το δέρμα σας να «αναπνέει»

  1. Damiani G, et al. COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study. Dermatologic Therapy, 2021;e14848
  2. Szepietowski JC, et al. Face mask-induced itch: A self-questionnaire study of 2315 responders during the COVID-19 pandemic. Acta Derm Venereol, 2020;100:adv00152
  3. Moshirfar M, et al. Face Mask-Associated Ocular Irritation and Dryness. Ophthalmol Ther. 2020 Sep; 9(3): 397–400. 
  4. Centre for Ocular Research & Education (CORE) and University of Waterloo. Mask associated dry eye. Available from: www.COVIDEyeFacts.org)
  5. https://www.usdermatologypartners.com/blog/maskne-is-the-new-acne/
  6. Yan Y, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatol Ther, 2020;e13310.
  7. Lupo M, Antioxidants and Vitamins in Cosmetics. Clinics in Dermatology, 2001;19:467-473
  8. Οδηγίες χρήσης Bepanthol® Sensiderm Eczema, Bayer 2015. 
  9. Stettler H. Improved itch relief with new product formulation for topical treatment in patients with mild-to-moderate atopic dermatitis: results from an exploratory trial. Key Opinions in Medicine, 2016;11(4):1-7.
  10. Οδηγίες Χρήσης Bepanthene Eye Drops, Bayer 2020.

Με περισσότερα από 70 χρόνια εξειδίκευση στη φροντίδα και την προστασία της ευαίσθητης επιδερμίδας, η Bepanthol® αποτελεί ένα από τα πιο αγαπημένα brands για την περιποίηση του δέρματος. Αποστολή της Bepanthol® είναι να δημιουργεί συνεχώς νέα ποιοτικά προϊόντα, με κλινικά αποδεδειγμένη αποτελεσματικότητα, που είναι κατάλληλα για το ευαίσθητο δέρμα.